Clinical Trial Update: A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated RO7105705 in healthy participants and in individuals with mild-to-moderate Alzheimer's disease; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• RO7105705

Snippet

Sponsor: Genentech, Inc. | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED